Stocks Recap: Rentech, Celldex Therapeutics, UniPixel Inc

Lakeway, TX -- (SBWIRE) -- 03/01/2013 -- Bestdamnpennystocks, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-

Rentech, Inc. (NYSE:RTK) shares climbed 3.80% to $2.73 after the company, on Feb. 27, announced plans to cease operations at, reduce staffing at, and mothball its research and development (R&D) Product Demonstration Unit (PDU), in Commerce City, CO, and to eliminate all related R&D activities. The Company's strategy is focused on more immediate growth opportunities within the energy industry that do not rely on new technologies.

Additionally, the company, on Jan. 22, announced that it will hold its 2012 4th quarter and year end conference call on Tuesday, March 19, 2013 at 11:00 a.m. PST, during which time ( Rentech's ) senior management will review the Company's financial results for the period and provide update on the business.

How Should Investors Trade RTK After The Recent Movement? Find Out Here

Celldex Therapeutics, Inc. (NASDAQ:CLDX) shares increased 3.70% and closed at $9.52 in yesterday’s session. The company will release fourth quarter and year end 2012 financial results on Thursday, March 7, 2013 before the U.S. financial markets open. Celldex executives will host a conference call at 8:30 a.m. ET on the same day to discuss 2012 financial and business results and to provide an update on key 2013 objectives.

Aditionally, CLDX’s stock had its price target raised by Oppenheimer from $10.00 to $13.00 in a research report released on Feb. 26. Oppenheimer currently has an outperform rating on the stock.

Is CLDX Strong Buy After The Recent Strong Gains? Get Free Trend Analysis Here

UniPixel Inc (NASDAQ:UNXL) shares jumped 3.51% and closed at $23.60 in the last trading session after UNXL’s shares price target has been raised to $31 from $24 at Craig-Hallum yesterday.

Additionally, the company reported results for the fourth quarter and year ended December 31, 2012. Revenues totaled $76,200 in 2012, as compared to $195,200 in 2011, reflecting the company's continued development stage status as it transitions to a production stage company. Net loss was $9.0 million or $(1.11) per share in 2012, as compared to a net loss of $8.6 million or $(1.20) per share in 2011.

Is UNXL a Buying Opportunity After The Recent Plunge? Don’t Miss Out Our Latest Report Here

About bestdamnpennystocks.com
Best Damn Penny Stocks’ team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer
The assembled information disseminated by Bestdamnpennystocks.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Bestdamnpennystocks.com does expect that investors will buy and sell securities based on information assembled and presented in Bestdamnpennystocks.com. PLEASE always do your own due diligence, and consult your financial advisor.